Doheny Asset Management /Ca Edwards Lifesciences Corp Transaction History

Doheny Asset Management /Ca

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$78.68 - $90.67 $200,634 - $231,208	-2,550 Closed	0 $0
Q4 2020 Feb 26, 2021	BUY	$71.69 - $91.23 $101,082 - $128,634	1,410 Added 123.68%	2,550 $233,000
Q3 2020 Nov 12, 2020	SELL	$67.19 - $87.44 $104,816 - $136,406	-1,560 Reduced 57.78%	1,140 $266,000
Q3 2020 Nov 12, 2020	BUY	$67.19 - $87.44 $104,816 - $136,406	1,560 Added 136.84%	2,700 $216,000
Q4 2019 Feb 11, 2020	SELL	$71.7 - $82.09 $5,019 - $5,746	-70 Reduced 5.79%	1,140 $266,000
Q3 2019 Nov 15, 2019	SELL	$61.55 - $75.43 $1,538 - $1,885	-25 Reduced 2.02%	1,210 $266,000
Q2 2019 Aug 14, 2019	SELL	$55.74 - $64.41 $1,393 - $1,610	-25 Reduced 1.98%	1,235 $228,000
Q1 2019 May 14, 2019	SELL	$47.89 - $64.05 $36,156 - $48,357	-755 Reduced 37.47%	1,260 $241,000
Q3 2018 Nov 14, 2018	SELL	$45.7 - $58.03 $5,484 - $6,963	-120 Reduced 5.62%	2,015 $351,000
Q2 2018 Aug 10, 2018	SELL	$42.45 - $51.3 $15,706 - $18,981	-370 Reduced 14.77%	2,135 $311,000
Q1 2018 May 17, 2018	SELL	$37.19 - $47.45 $35,888 - $45,789	-965 Reduced 27.81%	2,505 $349,000
Q4 2017 Feb 15, 2018	BUY	$33.79 - $39.39 $117,251 - $136,683	3,470	3,470 $391,000

1,417

470M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Doheny Asset Management /Ca, based on Form 13F filings with the SEC.

Stay updated on Doheny Asset Management /Ca with notifications on news.